Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Statement re Prospectus and Circular

20 Oct 2014 18:27

RNS Number : 8172U
Maven Income & Growth VCT PLC
20 October 2014
 



Joint Announcement

Prospectus and Circular

Maven Income and Growth VCT PLC ("Maven VCT 1"), Maven Income and Growth VCT 2 PLC ("Maven VCT 2"), Maven Income and Growth VCT 3 PLC ("Maven VCT 3"), Maven Income and Growth VCT 4 PLC ("Maven VCT 4") and Maven Income and Growth VCT 5 PLC ("Maven VCT 5") (together "the Companies" and each a "Company"). The Companies are managed by Maven Capital Partners UK LLP ("Maven").

The Boards of the Companies are pleased to announce the launch of the offers for subscription to raise, in aggregate, up to £18 million ("the Offers" and each an "Offer").

Full details of the Offers are contained in a prospectus ("the Prospectus"), which was published by the Companies today.

In contrast to previous offers by Maven VCTs, prospective investors can apply either to invest amounts of their choice in one or more of the Offers or invest an equal amount in each of the Companies pursuant to the Offers (subject to each relevant Offer not having closed prior to the Application Form being processed). The amount subscribed under each Offer will be invested into new ordinary shares of 10p each ("New Shares") in the relevant Company.

The Offers open today and will close at 12.00 noon on 28 April 2015 (unless fully subscribed by an earlier date or otherwise extended or closed at an earlier date at the Directors' discretion). Persons intending to apply under the Offers for the 2014/2015 tax year should note that the deadline for such applications is 12.00 noon on 1 April 2015.

Pursuant to individual offer agreements dated 20 October 2014 relating to each Offer between, among others, each relevant Company and Maven, Maven will receive a fee of an amount equal to 2.5% of the amounts remitted to each Company with an investor's application (including any amounts requested to be facilitated) in respect of applications accepted under that Offer less (i) an amount equal to any early investment incentive discounts being made available by the Company (as set out in the Prospectus) applicable in respect of applications accepted under the relevant Offer, and less (ii) any amounts that Maven has agreed to waive in respect of applications accepted under the relevant Offer. As Maven is a related party of each Company under the Listing Rules, the payment of such fee by each Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Further, William Nixon and his associates have expressed their intention, prior to the close of the Offers, to subscribe for up to £300,000 under the Offers (up to £60,000 in respect of each Company). As a director (in the case of Maven VCT 2, Maven VCT 3 and Maven VCT 4) or an associate of Maven (in the case of Maven VCT 1 and Maven VCT 5), William Nixon and, therefore, each of his associates, are each a related party of each Company under the Listing Rules and consequently each of these subscriptions is a transaction to which Listing Rule 11.1.10R applies.

The Companies will also shortly be posting to shareholders a joint circular ("the Circular") convening general meetings of the Companies to be held on:

 

· 20 November 2014 at 10.00 a.m. (Maven VCT 1)

· 20 November 2014 at 10.15 a.m. (Maven VCT 2)

· 20 November 2014 at 10.30 a.m. (Maven VCT 3)

· 20 November 2014 at 10.45 a.m. (Maven VCT 4)

· 20 November 2014 at 11.00 a.m. (Maven VCT 5)

 

to propose, amongst other things, granting authorities to the Companies to allot New Shares pursuant to the Offers. The Prospectus has been submitted to the Financial Conduct Authority and copies of the Circular and Prospectus will shortly be available for download from the Companies' websites:

· www.mavencp.com/migvct

· www.mavencp.com/migvct2

· www.mavencp.com/migvct3

· www.mavencp.com/migvct4

· www.mavencp.com/migvct5

 

and from the National Storage Mechanism (http://www.hemscott.com/nsm.do).

For further information, please contact: 

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

 

 

Maven Capital Partners UK LLP

Secretary

20 October 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRBRBDGLDDBGSG
Date   Source Headline
25th Aug 20239:38 amRNSIssue of Equity
21st Aug 20233:28 pmRNSStatement re Dividend Investment Scheme
21st Jul 202312:52 pmRNSHalf-year Report
13th Jul 20234:04 pmRNSTransaction in Own Shares
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
30th Jun 20234:22 pmRNSNet Asset Value and Interim Dividend
2nd Jun 20239:41 amRNSIssue of Equity
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
24th Apr 202312:51 pmRNSResult of AGM
19th Apr 20234:49 pmRNSTransaction in Own Shares
19th Apr 20231:05 pmRNSNet Asset Value - Dividend Investment Scheme
5th Apr 202312:29 pmRNSIssue of Equity
4th Apr 202311:43 amRNSNet Asset Value(s)
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
14th Mar 20234:31 pmRNSAnnual Financial Report
3rd Mar 20239:53 amRNSIssue of Equity
21st Feb 20234:41 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202311:06 amRNSDirector/PDMR Shareholding - Replacement
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:08 amRNSDirector/PDMR Shareholding
8th Feb 20239:43 amRNSIssue of Equity
1st Feb 20233:23 pmRNSUnaudited NAV and Proposed Final Dividend
12th Dec 20223:41 pmRNSDirectorate Change
12th Dec 20223:34 pmRNSStatement re Director's Other Quoted Directorships
9th Nov 20223:00 pmRNSResult of General Meeting
4th Nov 20222:35 pmRNSTransaction in Own Shares
31st Oct 20223:54 pmRNSTransaction in Own Shares
21st Oct 20222:45 pmRNSNet Asset Value(s)
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
26th Aug 202210:04 amRNSIssue of Equity
22nd Aug 20229:33 amRNSStatement re Dividend Investment Scheme
29th Jul 202211:25 amRNSHalf-year Report
21st Jul 20224:38 pmRNSTransaction in Own Shares
13th Jul 202211:19 amRNSNet Asset Value and Interim Dividend
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
6th Jun 20222:15 pmRNSIssue of Equity
26th May 20225:02 pmRNSTransaction in Own Shares
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
26th Apr 202210:51 amRNSIssue of Equity - Dividend Investment Scheme
21st Apr 20222:39 pmRNSStatement re Dividend Investment Scheme
6th Apr 20224:02 pmRNSNet Asset Value(s)
6th Apr 20221:45 pmRNSResult of AGM
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
21st Mar 20222:59 pmRNSPublication of Suppl.Prospcts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.